Tirzepatide drops: what the research actually says

What people usually mean when they search for tirzepatide drops

Most people who land on this topic have seen social-media posts or online listings promising tirzepatide in a liquid or sublingual form, often described as cheaper and easier than injections. It is worth being direct about what those products are: compounded or wholly unregulated liquids that are not approved by the MHRA, not dispensed through the licensed UK supply chain, and not covered by any clinical trial evidence the regulator has evaluated. The phrase "tirzepatide drops UK" circulates precisely because demand for tirzepatide is high and waiting lists for NHS access exist.

In the United States, compounding pharmacies have produced tirzepatide oral drops and similar liquid forms during periods of shortage, which is where much of the online content originates. UK law works differently. A medicine cannot be marketed to the public unless it holds a UK marketing authorisation, and no drop, liquid or sublingual tirzepatide product does. If a seller is offering it, they are operating outside the law. Our page on Mounjaro drops covers this territory in more detail for people who have specifically seen the Mounjaro brand mentioned alongside liquid claims.

Why the licensed form is an injection, and what that means for your decision

Tirzepatide is a large peptide molecule. Peptides are broken down in the digestive tract before they reach the bloodstream, which is why the authorised route of administration is subcutaneous injection rather than an oral liquid. Eli Lilly's clinical programme tested the injectable formulation in thousands of adults across the SURMOUNT-1 trial, producing average weight reductions of around 20% at the highest dose over 72 weeks. That evidence base exists for the injection. It does not exist for drops, because drops have not been through equivalent trials.

If the idea of injections feels like a barrier, that is a genuinely common concern and one worth discussing with a prescriber rather than resolving by switching to an unproven product. Many people find the auto-injector pen far less daunting in practice than they expected. You can read more about how tirzepatide works and what starting treatment involves. The evidence on whether tirzepatide drops work is also examined separately for people who want a fuller assessment, including a closer look at GLP-1 tirzepatide drops and the claims made about them.

The safety risk the MHRA has already flagged

Buying prescription medicines from sellers who operate outside the regulated supply chain carries real risks. The MHRA has warned publicly about counterfeit and unlicensed weight-loss products sold online, and enforcement has led to large seizures of fake pens and liquid formulations. Unlicensed products may contain the wrong dose, the wrong substance, or no active ingredient at all. Because drops bypass the standard clinical assessment, there is also no check on whether the medicine is appropriate for the individual, contraindications, drug interactions and dose suitability all go unreviewed.

The NHS guidance on weight management injections is clear that these medicines require a prescription from a qualified clinician following proper assessment. Reporting a suspect seller can be done through the MHRA's Yellow Card scheme, which also takes reports of suspected side effects. If you have already used a product sold as tirzepatide drops and have concerns, speaking to a GP or pharmacist quickly is the right step.

What a legitimate tirzepatide route in the UK actually involves

Through a GPhC-registered pharmacy like nume, the process is straightforward and fully regulated. You complete a free consultation; a GPhC-registered Independent Prescriber reviews your answers and medical history the same day. If tirzepatide is clinically suitable, a prescription is issued, the medicine is dispensed from licensed stock supplied through Eli Lilly's authorised UK chain, and it is delivered to you the following working day in plain packaging. There are no subscriptions, no hidden fees, and every repeat order goes through a fresh clinical review.

Treatment starts at 2.5mg (a tolerability dose to let your system adjust) and is titrated by your prescriber over time. For anyone curious about cost, our Mounjaro pricing guide gives honest market context without the misleading comparisons that some listings use. The full picture of available treatments, including the newer oral semaglutide option, is on our treatments page. If you want to understand the clinical team behind our prescribing decisions, you can read about our clinical oversight.